Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2022 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, February 2023
Slide 1: Supplementary Slides Q4 2022
SUPPLEMENTARY SLIDES Q4 2022 For the period ended December 31, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q4 2022 (In CAD millions unless otherwise noted) Q4 2022 Q4 2021 % Change (1) Consolidated Revenue $14,007 $12,757 ↑ +9.8% Adjusted EBITDA $1,493 $1,324 ↑ +12.8% Adjusted EBITDA Margin 10.7% 10.4% ↑ +30 bps Adjusted Net Earnings Avaliable to Common Shareholders $
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q4 2022 (In CAD millions unless otherwise noted) Q4 2022 Q4 2021 % Change (1) Total Retail Revenue $13,694 $12,486 ↑ 9.7% Retail Revenue - Food $9,514 $8,742 ↑ 8.8% Retail Revenue - Drug $4,180 $3,744 ↑ 11.6% Pharmacy and Healthcare Services $1,941 $1,728 ↑ 12.
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q4 2022 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +8.4% Basket Size(2) ≈ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +8.7